Signs of a shakeout in the Indian CRO segment are growing clearer, with a number of small and mid-sized units apparently having scaled down or put themselves on the block.
If a clutch of industry heads and investment bankers is to be believed, then fringe and smaller firms largely focused...






![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
